daratumumab,elotuzumab,dexamethasone,bortezomib,pomalidomide,ciltacabtagene autoleucel,jnj-68284528,ixazomib,carfilzomib,lenalidomide,idecabtagene vicleucel
bms,takeda,2seventy bio,janssen,abbvie
['cartitude-4', 'mmsm', 'karmma', 'karmma-3', 'cartitude']
aa11: conclusion: this a day we should celebrate as we have a single treatment without maintenance that showed impressive results. will i change the practice based on the cartitude-4 and karmma-3: absolutely #mmsm #myeloma #medtwitter #meded #asco23 #usmirc
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter